Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prozac 60mg capsules
0403030E0BBACAE
|
Prozac | Fluoxetine hydrochloride | Central Nervous System | No data available |
|
Proziere 5mg tablets
0406000T0BEAAAG
|
Proziere 5 | Prochlorperazine maleate | Central Nervous System | No data available |
|
Prozit 20mg/5ml oral solution
0403030E0BFAAAC
|
Prozit | Fluoxetine hydrochloride | Central Nervous System | No data available |
|
Pseudoephedrine 120mg modified-release capsules
0310000N0AAAAAA
|
Pseudoephedrine hydrochloride | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Pseudoephedrine 120mg modified-release tablets
0310000N0AAAVAV
|
Pseudoephedrine hydrochloride | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Pseudoephedrine 15mg/5ml / Brompheniramine 2mg/5ml soln SF
0310000N0AAAIAI
|
Pseudoephedrine hydrochloride | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Pseudoephedrine 22.5mg / Diphenhydramine 12.5mg/5ml soln SF
0304010N0AAATAT
|
Diphenhydramine hydrochloride (Antihistamine) | Diphenhydramine hydrochloride | Respiratory System | No data available |
|
Pseudoephedrine 30mg/5ml / Brompheniramine 4mg/5ml soln SF
0310000N0AAAJAJ
|
Pseudoephedrine hydrochloride | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Pseudoephedrine 30mg/5ml / Dextromethorphan 10mg/5ml soln
0309020AFAAAAAA
|
Pseudoephedrine hydrochloride/dextromethorphan hydrobromide | Pseudoephedrine hydrochloride/dextromethorphan hydrobromide | Respiratory System | No data available |
|
Pseudoephedrine 30mg/5ml / Triprolidine 1.25mg/5ml soln
0310000N0AAAHAH
|
Pseudoephedrine hydrochloride | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Psorin ointment
1305020F0BDAAAU
|
Psorin (Ointment) | Dithranol | Skin | No data available |
|
Psorin scalp gel
1309000V0BBAAAA
|
Psorin (Scalp) | Dithranol | Skin | No data available |
|
Psyquet XL 150mg tablets
0402010ABBKABBA
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 200mg tablets
0402010ABBKACAW
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 300mg tablets
0402010ABBKADAX
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 400mg tablets
0402010ABBKAEAY
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 50mg tablets
0402010ABBKAAAV
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psytixol 20mg/1ml solution for injection ampoules
0402020G0BCAAAA
|
Psytixol | Flupentixol decanoate | Central Nervous System | No data available |
|
Psytixol 40mg/2ml solution for injection ampoules
0402020G0BCABAC
|
Psytixol | Flupentixol decanoate | Central Nervous System | No data available |
|
Pubic flange large opening
22905859136
|
Pubic flange large opening | Urinal Systems | Incontinence Appliances | No data available |
|
Pubic pressure 25mm flange 13mm
22903409058
|
Pubic pressure 25mm flange 13mm | Urinal Systems | Incontinence Appliances | No data available |
|
Pubic pressure 25mm flange 17mm
22903409059
|
Pubic pressure 25mm flange 17mm | Urinal Systems | Incontinence Appliances | No data available |
|
Pubic pressure 25mm flange 19mm
22903409060
|
Pubic pressure 25mm flange 19mm | Urinal Systems | Incontinence Appliances | No data available |
|
Pubic pressure 25mm flange 22mm
22903409061
|
Pubic pressure 25mm flange 22mm | Urinal Systems | Incontinence Appliances | No data available |
|
Pubic pressure 32mm flange 22mm
22903409062
|
Pubic pressure 32mm flange 22mm | Urinal Systems | Incontinence Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.